How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Supply Chain Strategies & Solutions Article
Developing Win-Win Deals With Local Suppliers
By: Nicholas Link Download Article
Supply Chain Strategies & Solutions Article
How Integrated Delivery Networks Are Using Venture Capital To Shake Up The Supply Chain Model
By: Antony Koblish
Supply Chain Strategies & Solutions Article
Breaking Barriers: Creating An Outcomes-Based Contracting Strategy
Outcomes-based contracting is no easy feat but when conducted properly, it creates a synergistic model that can significantly improve outcomes.
Guides/Reports
2018 AHRMM Cost, Quality and Outcomes (CQO) Report on the Clinically Integrated Supply Chain
The AHRMM Cost, Quality, and Outcomes (CQO) Movement was launched in 2013 to advance the role of the health care supply chain in delivering b
White Papers
The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
The Expansion of Health Care Delivery Methods and Supply Chain Considerations Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic